GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Artrya Ltd (ASX:AYA) » Definitions » Other Current Payables

Artrya (ASX:AYA) Other Current Payables : A$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Artrya Other Current Payables?

Artrya's Other Current Payables for the quarter that ended in Dec. 2024 was A$0.00 Mil.

Artrya's quarterly Other Current Payables increased from Dec. 2023 (A$0.00 Mil) to Jun. 2024 (A$0.72 Mil) but then declined from Jun. 2024 (A$0.72 Mil) to Dec. 2024 (A$0.00 Mil).

Artrya's annual Other Current Payables declined from Jun. 2022 (A$1.04 Mil) to Jun. 2023 (A$0.88 Mil) and declined from Jun. 2023 (A$0.88 Mil) to Jun. 2024 (A$0.72 Mil).


Artrya Other Current Payables Historical Data

The historical data trend for Artrya's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artrya Other Current Payables Chart

Artrya Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Other Current Payables
- 1.04 0.88 0.72

Artrya Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Current Payables Get a 7-Day Free Trial - 0.88 - 0.72 -

Artrya Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Artrya Other Current Payables Related Terms

Thank you for viewing the detailed overview of Artrya's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Artrya Business Description

Traded in Other Exchanges
N/A
Address
1257 Hay Street, West Perth, Perth, WA, AUS, 6005
Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The company is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.

Artrya Headlines

No Headlines